Atlas Trials

Biomarker Study in Participants With Migraine

Clinical trial NCT02766517 · COMPLETED

Trial details

NCT number
NCT02766517
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Migraine Disorders
Start date
2016-09-28
Primary completion
2017-01-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.